ASTEC — Astec Lifesciences Balance Sheet
0.000.00%
- IN₹19.08bn
- IN₹24.59bn
- IN₹3.81bn
Annual balance sheet for Astec Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 3.39 | 5.54 | 4.73 | 4.71 | 5.75 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,177 | 3,147 | 1,952 | 1,925 | 1,712 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,304 | 5,157 | 4,989 | 3,985 | 3,411 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,232 | 3,514 | 4,292 | 5,316 | 4,967 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 6,776 | 8,968 | 9,794 | 9,749 | 8,814 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,223 | 4,906 | 5,262 | 3,972 | 3,657 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,684 | 5,003 | 5,601 | 6,056 | 6,467 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 3,092 | 3,965 | 4,194 | 3,693 | 2,347 |
| Total Liabilities & Shareholders' Equity | 6,776 | 8,968 | 9,794 | 9,749 | 8,814 |
| Total Common Shares Outstanding |